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MinireviewChecks and Balances between Cohesincing
and TranscriptionDale Dorsett1 and Judith A. Kassis2
The cohesin protein complex was discovered for its roles
in sister chromatid cohesion and segregation, and the
Polycomb group (PcG) proteins for their roles in epigenetic
gene silencing during development. Cohesin also controls
gene transcription via multiple mechanisms. Genetic and
molecular evidence from Drosophila argue that cohesin
and the PRC1 PcG complex interact to control transcrip-
tion of many active genes that are critical for development,
and that via these interactions cohesin also controls the
availability of PRC1 for gene silencing.Introduction
Development of an organism requires temporal and spatial
control of gene transcription. The Polycomb group (PcG)
proteins, first described in Drosophila, epigenetically main-
tain gene silencing through cell division, and thereby help
define the developmental fates of cell lineages. Although
the cohesin complex was first recognized for its role in
chromosome segregation and cell division, it has become
apparent that it also plays multiple direct and essential
roles in transcription of active genes important for growth
and development. It has been assumed that cohesin
and PcG complexes by and large play independent and
generally antagonistic roles to each other in the transcrip-
tion of key developmental genes. Recent evidence from
Drosophila, however, unexpectedly reveals that cohesin
and the PRC1 PcG complex directly and functionally
interact to modulate both gene silencing and transcription
of active genes. These findings raise intriguing questions
regarding the potential roles of such interactions in human
development and cancer. Here, we provide a brief review
of the roles of cohesin and PcG proteins in gene expres-
sion, and then discuss the evidence for cohesin–Polycomb
interactions and the current ideas about the functions of
these interactions.Functions of Polycomb Complexes in Gene Silencing
and Development
The Polycomb proteins were discovered in genetic screens
in Drosophila based on their dominant loss-of-function
homeotic phenotypes, and have since been found to be
critical regulators of stem cell identity, embryonic develop-
ment, and oncogenesis in mammals [1–3]. Molecular and
biochemical studies have shown that many of the Poly-
comb proteins are present in complexes that modify chro-
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contains a methyltransferase, Enhancer of zeste [E(z)], that
methylates the lysine 27 residue of histone H3 to form
H3K27me3, a modification that spreads in large domains
of many kilobase pairs (kbp) over silenced genes. The Poly-
comb (Pc) subunit of the PRC1 complex contains a chro-
modomain that binds to H3K27me3, thereby assisting the
spread of PRC1 over large regions. PRC1 contains the
Sex combs extra (Sce, dRing) subunit, which mono-ubiqui-
tinates the carboxy-terminal tail of histone H2A to form
H2Aub, a modification that can also spread over large
regions (Figure 1A) [4]. H2Aub is present only at low levels
over some silenced genes, which may reflect de-ubiquitina-
tion by another Polycomb complex, PR-DUB [5]. Current
evidence argues that the histone modifications made by
PcG complexes are critical for silencing at many, but not
all, genes [2,3,5].
In Drosophila, Polycomb protein complexes are recruited
via DNA binding proteins to Polycomb Response Elements
(PREs) while Polycomb recruitment in mammals occurs via
multiple mechanisms, including both PRE-like mechanisms
and via interactions with long non-coding RNAs [3,6,7].
In contrast to Drosophila, vertebrates also have several
different PRC1 and PRC2 complexes, reflecting the pres-
ence of multiple orthologs of key subunits. For instance,
CBX2, CBX4, CBX6, CBX7, and CBX8 are all Pc orthologs,
and appear to have cell-type-specific functions [2].
The Cohesin Complex Mediates Sister Chromatid
Cohesion and Influences Development in a
Dosage-Sensitive Manner
The cohesin protein complex and associated regulatory
factors (Figure 1B) were originally discovered in yeast ge-
netic screens and vertebrates because they are essential
for mitotic and meiotic sister chromatid cohesion, but
they also participate in DNA repair and gene transcription
[8–10]. The Smc1, Smc3, Rad21 and Stromalin (SA) cohesin
subunits form a ring-like structure that encircles DNA.
Cohesin is topologically loaded along chromosomes during
interphase by the kollerin complex consisting of the Nip-
ped-B adherin and the Mau-2 protein, and is removed by
the releasin complex consisting of Pds5 and Wapl. Sister
chromatid cohesion ensures accurate chromosome segre-
gation upon cell division. Thus, severe disruption of cohesin
function results in aneuploidy and frequent cell death. How-
ever, studies in Drosophila, zebrafish, mouse, and human
reveal that reduced cohesin or kollerin dosage alters gene
expression and development without evident defects in
sister chromatid cohesion and chromosome segregation
[8]. In humans, reduced dosage of the NIPBL (Nipped-B-
Like) kollerin subunit and missense mutations in cohesin
subunits cause Cornelia de Lange syndrome (CdLS), which
displays diverse structural and mental birth defects [11].
Mutations affecting the HDAC8 deacetylase that recycles
the SMC3 cohesin subunit and reductions in Rad21 func-
tion cause phenotypes closely overlapping those seen in
CdLS [12,13]. Collectively these syndromes are known as
cohesinopathies.
Figure 1. The Polycomb repressive com-
plexes and cohesin.
(A) The two major Polycomb complexes are
PRC2, which contains the Enhancer of zeste
[E(z)] subunit that trimethylates histone H3
lysine 27 (me3) upon recruitment to a PRE.
The Polycomb (Pc) subunit of the PRC1 com-
plex binds H3K27me3, and the Sex combs ex-
tra (Sce, dRing) subunit mono-ubiquitinates
histone H2A on lysine residue 118 (ub). (B)
The cohesin complex consists of the Smc1,
Smc3, Stromalin (SA) and Rad21 subunits. It
is loaded topologically onto chromosomes
by the kollerin complex, consisting of the
Nipped-B and Mau-2 proteins throughout
interphase. Cohesin is continuously removed
from chromosomes by the releasin complex,
consisting of the Wapl and Pds5 proteins.
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Control Growth and Development
A role for cohesin in gene expression was revealed in a
genetic screen designed to detect genes that facilitate
communication between distant transcriptional enhancers
and promoters. Since that time, cohesin’s role in enhancer–
promoter communication has been confirmed in fly and
mammalian cells [14–19]. In particular, chromosome con-
formation capture (3C) experiments argue that one role of
cohesin is to facilitate enhancer–promoter communication
by stabilizing long DNA loops. In fact, genome-wide map-
ping of long-range interactions using techniques derived
from 3C confirm that cohesin is critical for many long-range
gene regulatory interactions [20–23].
Genome-wide studies in Drosophila and mammalian cells
reveal that cohesin binds to a large subset of transcriptionally
active genes, many of which encode transcription and sig-
naling factors important for growth and development [8].
Cohesin binding is high near active transcription start
sites and transcriptional enhancers, but is generally unde-
tectable at Polycomb silenced genes marked by H3K27me3
[16,18,24,25]. Gene promoters that bind cohesin show a
high level of transcriptional pausing, where RNA polymerase
II (Pol II) transcribes some 30 to 40 nucleotides and then
stops before it is released into elongation (Figure 2) [18,26].
Transition from pausing to elongation requires phosphory-
lation of the NELF (negative elongation factor) and DSIF
(DRB sensitivity inducing factor) pausing complexes, and
the serine 2 residues of the heptapeptide repeats in the
carboxy-terminal domain (CTD) of the Rpb1 Pol II subunit
(Figure 2) [27]. Depending on the gene and cell type, cohesin
can either facilitate or hinder the transition of paused Pol II to
elongation [18,26]. Inmany cases this likely reflects cohesin’s
role in enhancer–promoter communication, but cohesin also
appears to have additional roles at the promoters of many
genes [18].
Cohesin–Polycomb Interactions
Genetic studies suggest an antagonistic connection be-
tween Polycomb proteins and cohesin [28–31]. In particular,
mutations in releasin genes increase cohesin binding and
counteract Polycomb silencing, whereas decreasing cohe-
sin dosage or chromosome binding enhances Polycomb
silencing. The in vivo antagonism between cohesin and
PRC1 fits nicely with the discovery that silenced genesmarked by the PRC2-generated H3K27me3 modification
do not bind cohesin, outside of narrow peaks at some
PREs [25]. Combined with the genetic studies, this led to
the early view that cohesin may help prevent spreading of
Polycomb complexes into active genes, and vice versa.
This view, however, was challenged by the unexpected
discovery that cohesin subunits co-purify with the PRC1
complex from Drosophila nuclear extracts [32]. This model
also didn’t explain how a small number of genes broke the
general rule, with cohesin spreading across large domains
of several kbp together with H3K27me3 and H2Aub [4,33].
These rare genes all encode key developmental regulators,
such as the invected and engrailed homeobox genes, the
Enhancer of split gene complex, and the Psc and Su(z)2
Polycomb genes. This unusual cohesin–H3K27me3–H2Aub
state proved to be cell-type dependent, and when it occurs,
the genes are not fully silenced, and depletion of either
cohesin or PRC1 causes large increases in transcription.
Like ‘poised’ bivalent genes in mammalian cells [34] these
genes also have the H3K4me3 histone modification, a mark
of active genes, at the transcription start site.
The recent discovery that PRC1 is present at active cohe-
sin-binding genes resolves the paradoxical findings that co-
hesin and PRC1 interact biochemically, while PcG-silenced
genes lack cohesin [31]. This discovery arose from studies
on the PcG-regulated genes invected and engrailed in the
developing wing imaginal disc. The invected and engrailed
genes encode homeoproteins that determine posterior
identity and are expressed in the posterior compartment of
the larval wing imaginal disc but are Polycomb-silenced in
the anterior compartment. Genomic ChIP on chromatin pre-
pared separately from posterior and anterior compartments
showed that, as expected, cohesin is present at high levels
on these genes only in the posterior cells where they are
transcribed, and H3K27me3 is high only in anterior cells,
where they are silenced. Unexpectedly, however, multiple
PRC1 subunits, including Pc, Ph and Psc, are present at
virtually equal levels in both posterior and anterior disc cells
[31,35]. The presence of multiple subunits indicates that
the core PRC1 complex is present at both the active and
silenced invected and engrailed genes [31]. PcG protein
binding at PREs of the active Ubx (Ultrabithorax) gene in
the haltere imaginal disc has also been reported [36].
Unexpectedly, genome-wide mapping of three PRC1
subunits in wing discs reveals PRC1 binding within the
Figure 2. The PRC1 sequestration model.
Genomic chromatin immunoprecipitation
shows that in Drosophila, PRC1 is distributed
between Polycomb silenced genes (left),
marked with H3K27me3 made by the PRC2
complex, and active genes (right) that bind
cohesin. The bulk of PRC1 is present at active
genes, and upon reduction in cohesin levels,
PRC1 released from active genes relocates
to silenced genes, indicating that sequestra-
tion of PRC1 by cohesin at active genes limits
the amount of PRC1 available for silencing.
This model is consistent with the in vivo ge-
netic antagonismbetween PRC1 and cohesin.
RNA polymerase (Pol II) at cohesin-binding
promoters is transcriptionally paused by the
NELF and DSIF pausing factors. Phosphoryla-
tion (pink circles) of NELF, DSIF and Pol II by
the P-TEFb kinase releases Pol II into elonga-
tion. Current data argue that PRC1 prevents
premature release of paused Pol II into elongation before it is fully phosphorylated (see text). In rare cases, some genes marked by
H3K27me3 also bind cohesin (restrained). These genes also bind PRC1, but are not silenced. Both PRC1 and cohesin are needed to keep tran-
scription at a low level. It is currently unknown if this special state represents a transition between the silenced and active states, or is a special
state that maintains transcription at a critical level. These cases are very similar to bivalent genes seen in mammalian embryonic stem cells. This
figure is adapted from [31].
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highly-transcribed constitutively expressed genes, such as
myc, and multiple ribosomal protein genes that lack
H3K27me3. Importantly, PRC1 binding to active genes is
restricted to those that bind cohesin. Genomic ChIP in
cultured cells, a more homogenous cell population, confirms
that there is extensive cohesin–PRC1 overlap on active
genes, although H2Aub levels are low to undetectable [4,31].
ChIP cannot determine if cohesin and PRC1 co-occupy
active genes, or if there is switching back and forth between
cohesin-only and PRC1-only conditions. Additional evi-
dence, however, strongly supports co-occupancy. Depletion
of cohesin in cultured cells decreases the levels of PRC1 at
active genes, and simultaneously increases PRC1 levels at
silenced genes marked by H3K27me3 [31]. Combined with
the prior finding that cohesin and PRC1 interact biochemi-
cally [32], this argues that cohesin recruits PRC1 and/or
stabilizes PRC1 binding at active genes. The increase in
PRC1 at silenced genesmarked by H3K27me3 upon cohesin
depletion further argues that cohesin sequesters enough
PRC1 at active genes to limit the amount of PRC1 available
for binding to silenced genes (Figure 2). Reducing cohesin
releases PRC1 to relocate to silenced genes marked by
H3K27me3.
This model can explain the in vivo antagonism between
cohesin and PRC1. When a heterozygous Pcmutation limits
the amount of PRC1 available for silencing, resulting in ho-
meotic transformations, reducing cohesin dosage releases
sufficient PRC1 from active genes to restore silencing. In
this view, the increased cohesin binding that occurs in pds5
and wapl releasin mutations sequesters too much PRC1 at
active genes, mimicking the effect of PRC1 mutations. In
the presence of normal PRC1 levels, cohesin and Nipped-B
mutations result in excess available PRC1, and over-silenc-
ing that causes homeotic transformations opposite to those
caused by Pc mutations [28,31]. This model differs sig-
nificantly from the earlier view, in which cohesin and PRC1
battle for binding to a gene, with the winner determining
whether the gene is active or silenced. A key point of the
sequestration model is that the cohesin at active genesbalances the levels of PRC1 to ensure appropriate levels
of gene silencing. This raises the intriguing possibility that
substantial changes in active gene transcription can cause
global changes in gene silencing.
The PRC1 Complex Modifies RNA Polymerase Function
at Active Genes
Do PcG proteins have a regulatory function at active
cohesin-binding genes? The evidence suggests that PRC1
promotes polymerase pausing. Upon depletion of the Ph
subunit of PRC1 in cultured cells, the total level of Pol II
within active gene bodies increases, but the level of serine
2 phosphorylated Pol II decreases, correlating with lower
mRNA levels [31]. Although H2Aub is usually undetectable
at active genes, depletion of the PRC1 subunit Sce that
ubiquitinates H2A has the same effect as Ph depletion on
Pol II, raising the possibility that transient H2A modification
may contribute to transcriptional pausing (Z. Misulovin,
A. Koenig, C.A. Schaaf, D.D., unpublished).
Phosphorylation of the Pol II CTD by P-TEFb facilitates
binding of elongation and RNA processing proteins needed
to produce mRNA from the nascent transcripts. Therefore,
a likely role for PRC1 at active genes is to prevent Pol II
from entering into elongation until the pausing factors and
Pol II have been fully phosphorylated. In the absence of
PRC1, entry of incompletely phosphorylated Pol II decreases
binding of RNA processing factors needed for efficient
mRNA production, and could also reduce binding of elonga-
tion factors and the rate of nascent RNA synthesis.
The effect of depleting PRC1 on transcription differs from
that of cohesin depletion. Cohesin depletion reduces both
cohesin and PRC1 binding, and there is usually a decrease
in both total and phosphorylated Pol II in the bodies
of active genes [18]. Depletion of PRC1, however, rarely
decreases cohesin levels, and thus cohesin remains at
the active genes and appears to be required for the in-
crease in Pol II in gene bodies. It is unclear how cohesin
facilitates the entry of Pol II into the gene body before it
is fully phosphorylated. This finding suggests, however,
that in addition to its role in facilitating enhancer–promoter
Current Biology Vol 24 No 11
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function at the promoter.
The proposed function of PRC1 at active gene promoters
is likely to be closely related to its role in silencing. General
transcription factors are present at some PcG-silenced pro-
moters, but there is little or no transcription, suggesting that
Pol II is restrained by PRC1 [37]. Although most silenced
genes marked by H3K27me3 lack paused Pol II, lack of the
Esc (extra sex combs) protein essential for PRC2 activity
in embryos leads to the appearance of promoter-proximal
paused Pol II at many inactive genes, suggesting that
PRC1 is still present and blocks entry of Pol II into elongation
[38]. Similarly, PRC1 restrains paused Pol II at bivalent gene
promoters in mouse embryonic stem cells [34,39].
Does PRC1 Participate in Enhancer–Promoter Looping?
The functional interactions between cohesin and PRC1
raise the question of whether or not PRC1 supports cohe-
sin’s role in long-range enhancer–promoter looping. Indeed,
it has recently been reported that PRC1 facilitates an
enhancer–promoter interaction to activate the Meis2 gene
in developing mouse midbrain [40]. Long-range looping
and interchromosomal interactions between PREs have
been intensively studied in Drosophila since the discovery
of chromosome pairing-dependent silencing by a PRE
from the engrailed gene, and the data clearly demonstrate
extensive long-range looping between active PREs [41–43].
However, analysis of genome-wide PRC1 mapping data
[31] reveals that while cohesin binds to essentially all active
distant enhancers, and PRC1 is present at virtually all
cohesin-binding promoters, PRC1 is detected at only a third
of the distant enhancers (D.D., unpublished). This is similar
to the frequency with which Pol II is detected at the distant
enhancers, and cohesin depletion similarly reduces both
Pol II and PRC1 levels at enhancers. The simplest inter-
pretation, therefore, is that the PRC1 and Pol II detected
at the enhancers are actually bound to the promoter, but
enhancer–promoter looping allows some crosslinking to
the enhancer. This argues against the general idea that
PRC1 contributes to enhancer–promoter looping. In con-
trast, 3C analysis supports the idea that cohesin, which
can be detected at many PREs at silenced genes, supports
looping between the PREs upstream of the invected and
engrailed genes [31].
Are Cohesin–PRC1 Interactions Important For Human
Development and Cancer?
The cohesin–PRC1 interactions detected in Drosophila may
have implications for human cohesinopathies and cancers.
Cells from individuals with genetically distinct forms of
CdLS show similar patterns of changes in gene expression
[24], supporting the view that cohesin’s role in controlling
transcription is central to CdLS etiology. New evidence indi-
cates that PRC1 regulates transcription of many active
genes in quiescent mouse lymphocytes [44] and is present
at several active genes in human fibroblasts [45]. The gener-
ality of these intriguing findings has yet to be explored, but
if cohesin controls association of mammalian PRC1 with
active genes and balances gene silencing, increases in
gene silencing may contribute to the development deficits
that occur in cohesinopathies. There are also potential roles
of cohesin–PRC1 interactions in cancer, given the striking
correlation between high levels of cohesin and poor prog-
nosis in many tumors, the frequent occurrence of cohesinand PcG protein mutations in cancer, and the evolutionarily
conserved positive modulation of myc gene transcription
by cohesin [2,46,47].
Looking Forward
Given the high sensitivity of Drosophila gene expression and
development to functional cohesin–PRC1 interactions, and
the potential involvement of such interactions in human
development and cancer, it is important to determine if and
how similar interactions occur in mammals. Addressing
this question, however, is complicated by the diversity of
mammalian PRC1 complexes. It is possible, for example,
that only one or a few of the many human PRC1 complexes
work together with cohesin. Mammals also have two
forms of cohesin in somatic cells that differ in their roles in
gene regulation, adding additional complexity [48]. Better
definition of the molecular interactions between Drosophila
PRC1 and cohesin may be helpful in the search for
cohesin–PRC1 interactions in vertebrates. Knowing which
residues of which cohesin subunits interact with which
residues of which PRC1 subunits could potentially eliminate
some mammalian PRC1 complexes from consideration, and
highlight others as likely candidates.
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